PET evidence that loxapine is an equipotent blocker of 5-HT2 and D2 receptors: implications for the therapeutics of schizophrenia. (Q48600255)
Jump to navigation
Jump to search
scientific article published in November 1997
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | PET evidence that loxapine is an equipotent blocker of 5-HT2 and D2 receptors: implications for the therapeutics of schizophrenia. |
scientific article published in November 1997 |
Statements
PET evidence that loxapine is an equipotent blocker of 5-HT2 and D2 receptors: implications for the therapeutics of schizophrenia (English)
Kapur S
Zipursky R
Remington G
Jones C
1 November 1997